Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD)

Frontiers in Cellular Neuroscience

Volumn , Issue AUG, 2013, Pages

  Lukiw, Walter J ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African american; Alzheimer's disease; Caucasian american; Human biochemical individuality; Human populations; miRNA profiling; MiRNA speciation; Superior temporal lobe neocortex

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 125B; MICRORNA 146A; MICRORNA 155; MICRORNA 34A; MICRORNA 9;

ALZHEIMER DISEASE; ARTICLE; BODY MASS; BRAIN REGION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INNATE IMMUNITY; MOLECULAR EVOLUTION; NEUROPATHOLOGY; PHENOTYPIC VARIATION; POINT MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENILE PLAQUE;

EID: 84885027485     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2013.00133     Document Type: Article

References (37)

1. Alzheimer Association. (2013). Alzheimer's Disease Facts and Figures Statistical Resource. Available online at: http://www.alz.org/downloads/Facts Figures2013.pdf.
2. Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., and Lukiw, W. J. (2002). Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor downregulation and up-regulation of apoptotic and pro-inflammatory signaling. J. Neurosci. Res. 70, 462-473. doi: 10.1002/jnr.10351
3. Colantuoni, C., Lipska, B. K., Ye, T., Hyde, T. M., Tao, R., Leek, J. T., et al. (2011). Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 478, 19-23. doi: 10.1038/nature10524
4. Cowley, M. J., Cotsapas, C. J., Williams, R. B., Chan, E. K., Pulvers, J. N., Liu, M. Y., et al. (2009). Intra-and inter-individual genetic differences in gene expression. Mamm. Genome20, 281-295. doi: 10.1007/s00335-009-9181-x
5. Cui, J. G., Zhao, Y., and Lukiw, W. J. (2005). Isolation of high spectral quality messenger RNA (mRNA) using run-on gene transcription; application to gene expression profiling of human brain. Cell. Mol. Neurobiol. 25, 789-794. doi: 10.1007/s10571-005-4035-x
6. Cui, J. G., Li, Y. Y., Zhao, Y., Bhattacharjee, S., and Lukiw, W. J. (2010). Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-kappaB in stressed human astroglial cells and in Alzheimer disease. J. Biol. Chem. 285, 38951-38960. doi: 10.1074/jbc.M110.178848
7. Culpan, D., Kehoe, P. G., and Love, S. (2011). Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro. Int. J. Mol. Epidemiol. Genet. 2, 156-162.
8. Espino, D. V., and Lewis, R. (1998). Dementia in older minority populations; issues of prevalence, diagnosis, and treatment. Am. J. Geriatr. Psychiatry 6, S19-S25. doi: 10.1097/00019442-199821001-00003
9. Froehlich, T. E., Bogardus, S. T. Jr., and Inouye, S. K. (2001). Dementia and race: are there differences between African Americans and Caucasians.J. Am. Geriatr. Soc. 49, 477-484. doi: 10.1046/j.1532-5415.2001.49096.x
10. Ginsberg, S. D., Alldred, M. J., and Che, S. (2012). Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease. Neurobiol. Dis. 45, 99-107. doi: 10.1016/j.nbd.2011.07.013
11. Hu, K., Xie, Y. Y., Zhang, C., Ouyang, D. S., Long, H. Y., Sun, D. N., et al. (2012). MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neuron cell apoptosis post-status epilepticus. BMC Neurosci. 13:115. doi: 10.1186/1471-2202-13-115
12. Hulse, A. M., and Cai, J. J. (2013). Genetic variants contribute to gene expression variability in humans. Genetics 193, 95-108. doi: 10.1534/ genetics.112.146779
13. Iyer, A., Zurolo, E., Prabowo, A., Fluiter, K., Spliet, W. G., van Rijen, P. C., et al. (2012). MiRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS ONE 7:e44789. doi: 10.1371/ journal.pone.0044789
14. Kostic, A. D., Howitt, M. R., and Garrett, W. S. (2013). Exploring host-microbiome interactions in animal models and humans. Genes Dev. 27, 701-718. doi: 10.1101/gad.212522.112
15. Li, J., Liu, Y., Kim, T., Min, R., and Zhang, Z. (2010). Gene expression variability within and between human populations and implications toward disease susceptibility. PLoS Comput. Biol. 6:e1000910. doi:10.1371/journal.pcbi.1000910
16. Lukiw, W. J. (2007). Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. Neuroreport 18, 297-300. doi: 10.1097/WNR. 0b013e3280148e8b
17. Lukiw, W. J., and Pogue, A. I. (2007). Induction of specific micro RNA (miRNA) species by ROSgenerating metal sulfates in primary human brain cells. J. Inorg. Biochem. 101, 1265-1269. doi: 10.1016/j.jinorgbio.2007.06.004
18. Lukiw, W. J., Dua, P., Pogue, A. I., Eicken, C., and Hill, J. M. (2011). Up-regulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler Scheinker (GSS) syndrome. J. Toxicol. Environ. Health 74, 1460-1468. doi: 10.1080/15287394.2011. 618973
19. Lukiw, W. J. (2012a). NF-kB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp. Neurol. 235, 484-490. doi: 10.1016/j.expneurol.2011.11.022
20. Lukiw, W. J. (2012b). Evolution and complexity of micro RNA in the human brain. Front. Genet. 3:166. doi: 10.3389/fgene.2012.00166
21. Lukiw, W. J. (2013). Antagonism of NF-κB-upregulated micro RNAs (miRNAs) in sporadic Alzheimer's disease (AD); anti-NF-κB versus anti-miRNA strategies. Front. Genet. 4:77. doi: 10.3389/fgene.2013.00077
22. McLachlan, D. R., Lukiw, W. J., and Kruck, T. P. (1989). New evidence for an active role of aluminum in Alzheimer's disease. Can. J. Neurol. Sci. 16, 490-497.
23. Nussbaum, R. L. (2013). Genome-wide association studies, Alzheimer disease, and understudied populations. JAMA 309, 1527-1528. doi: 10.1001/jama.2013.3507
24. Olson, M. V. (2012). Human genetic individuality. Annu. Rev. Genomics Hum. Genet. 13, 1-27. doi: 10.1146/annurev-genom-090711-163825
25. Pauling, L. (1976). Vitamin C and the Common Cold. WH Freeman, San Francisco CA: WH Freeman Press.
26. Raj, A., Kuceyeski, A., and Weiner, M. (2012). A network diffusion model of disease progression in dementia. Neuron 73, 1204-1215. doi: 10.1016/j. neuron.2011.12.040
27. Raj, A., Rifkin, S. A., Andersen, E., and van Oudenaarden, A. (2010). Variability in gene expression underlies incomplete penetrance. Nature 463, 913-918. doi: 10.1038/nature08781
28. Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B. N., Wang, L. S., et al. (2013). Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E {small element of}4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 309, 1483-1492. doi: 10.1001/jama.2013.2973
29. Saba, R., Gushue, S., Huzarewich, R. L., Manguiat, K., Medina, S., Robertson, C., et al. (2012). MicroRNA 146a (miR-146a) is over-expressed during prion disease and modulates the innate immune response and the microglial activation state. PLoS ONE. 7:e30832. doi:10.1371/journal.pone.0030832
30. Sethi, P., and Lukiw, W. J. (2009). Micro-RNA (miRNA) abundance and stability in human primary brain cells and in human brain tissues. Neurosci. Lett. 459, 100-104. doi: 10.1016/j.neulet.2009.04.052
31. Shadlen, M. F., Larson, E. B., Gibbons, L., McCormick, W. C., and Teri, L. (1999). Alzheimer's disease symptom severity in blacks and whites. J. Am. Geriatr. Soc. 47, 482-486.
32. Tang, M. X., Stern, Y., Marder, K., Bell, K., Gurland, B., Lantigua, R., et al. (1998). The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 279, 751-755. doi: 10.1001/jama.279. 10.751
33. Venketasubramanian, N., Sahadevan, S., Kua, E. H., Chen, C. P., and Ng, T. P. (2010). Interethnic differences in dementia epidemiology: global and Asia-Pacific perspectives. Dement. Geriatr. Cogn. Disord. 30, 492-498. doi: 10.1159/000 321675
34. Wang, X., Liu, P., Zhu, H., Xu, Y., Ma, C., Dai, X., et al. (2009). miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. Brain Res. Bull. 80, 268-273. doi: 10.1016/j.brainresbull.2009.08.006
35. Williams, R. B., Chan, E. K., Cowley, M. J., and Little, P. F. (2007). The influence of genetic variation on gene expression. Genome Res. 17, 1707-1716. doi: 10.1101/gr.6981507
36. Zhao, Y., Bhattacharjee, S., Jones, B. M., Dua, P., Alexandrov, P. N., Hill, J. M., et al. (2013). Regulation of TREM2 expression by an NF-êBsensitive miRNA-34a. Neuroreport 24, 318-323. doi: 10.1097/WNR.0b013e32835fb6b0
37. Zheng, W., Gianoulis, T. A., Karczewski, K. J., Zhao, H., and Snyder, M. (2011). Regulatory variation within and between species. Annu. Rev. Genomics Hum. Genet. 12, 327-346. doi: 10.1146/annurevgenom-082908-150139